🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today, the FDA hosted the 1st day of the public meeting, Pediatric Medical Device Development. You can register on-site, so we hope more join us tomorrow! #Devices4kids fda.gov/MedicalDevices…

Looking forward to another thought-provoking day here at the Pediatric Medical Device Development Workshop #devices4kids

The public comment period gives the FDA/CDRH Industry, and everyone that is in attendance at the public meeting, the chance to hear new voices and their perspectives #devices4kids

Remembering a legend #devices4kids

Welcome to Philadelphia and The MedTech Conference! See you tomorrow for the official kickoff. #MedTechCon

Real world evidence has the potential to advance pediatric device development Johnson & Johnson NESTcc Children's Health AdvaMed #Innovate4kids #MedTechCon #devices4kids

CDRH’s Dr. Eric Chen, Director, HUD and PDC Programs U.S. FDA #MedTechCon #devices4kids #innovate4kids

We hope this extra time will allow stakeholders to continue to provide input on the ideas shared during the two-day Pediatric Device Development public meeting held last month. #devices4kids go.usa.gov/xPjwm

We value and support broad stakeholder engagement and input as we continue to innovate for children #devices4kids #Innovate4Kids #anddevices

Wonderful to experience so much expertise, talent and passion aligning to enhance medical device innovation and healthcare for children #devices4kids #Innovate4Kids #anddevices

Innovation in #Pediatrics means innovation for everyone. Honored to engage with regulatory professionals across the world helping ensure safe and effective medical products save and improve lives #RAPS2018 #devices4kids #anddevices

Patient-focused medical product development is a priority for the FDA- Looking forward to moderating discussions on what’s important in the selection and use of clinical outcomes assessments (COA) for people living with health concerns FDA Drug Information fda.gov/Drugs/NewsEven…

Special populations (i.e. children, seniors, the cognitively impaired) require unique considerations as we develop and implement COAs-Privileged to guide internal and external experts as we continue to enhance medical products for everyone FDA Drug Information fda.gov/Drugs/NewsEven…

Digital Health and Patient Engagement, a potent combination #peac2018 #anddevices